Format
Sort by

Send to

Choose Destination

Search results

Items: 3

1.

The Lim1 oncogene as a new therapeutic target for metastatic human renal cell carcinoma.

Hamaidi I, Coquard C, Danilin S, Dormoy V, BĂ©raud C, Rothhut S, Barthelmebs M, Benkirane-Jessel N, Lindner V, Lang H, Massfelder T.

Oncogene. 2018 Aug 3. doi: 10.1038/s41388-018-0413-y. [Epub ahead of print]

PMID:
30076415
2.

An FGFR3/MYC positive feedback loop provides new opportunities for targeted therapies in bladder cancers.

Mahe M, Dufour F, Neyret-Kahn H, Moreno-Vega A, Beraud C, Shi M, Hamaidi I, Sanchez-Quiles V, Krucker C, Dorland-Galliot M, Chapeaublanc E, Nicolle R, Lang H, Pouponnot C, Massfelder T, Radvanyi F, Bernard-Pierrot I.

EMBO Mol Med. 2018 Apr;10(4). pii: e8163. doi: 10.15252/emmm.201708163.

3.

Polydiacetylenic nanofibers as new siRNA vehicles for in vitro and in vivo delivery.

Neuberg P, Hamaidi I, Danilin S, Ripoll M, Lindner V, Nothisen M, Wagner A, Kichler A, Massfelder T, Remy JS.

Nanoscale. 2018 Jan 25;10(4):1587-1590. doi: 10.1039/c7nr09202d.

PMID:
29322141

Supplemental Content

Loading ...
Support Center